Personalized antibiotic strategy may be preferred for left-sided infective endocarditis

MUNICH — In patients with left-sided infective endocarditis, a response-tailored antibiotic strategy conferred more time alive without antibiotic therapy compared with standard duration therapy, new data show. For the POET II trial, presented at the European Society of Cardiology Congress and simultaneously published in The New England Journal of Medicine, the researchers randomly assigned